Cereno Scientific Announces First Peer-Reviewed Publication on HDAC Inhibitor CS014: Antithrombotic Efficacy Without Bleeding Risk Supports Broad Potential in Cardiopulmonary ...

Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with ...

Cadrenal Therapeutics Highlights High Incidence of Thrombotic Complications in Heparin-Induced Thrombocytopenia (HIT) at the J.P. Morgan Healthcare Conference and VLX-1005 as a ...

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today highlighted the ...
Morning Overview on MSN

Ocean sugars can trigger cancer cells to self-destruct, study suggests

From the deep sea to the shallow seafloor, researchers are uncovering unusual sugars that do something extraordinary to ...
Express Healthcare

Sysmex coagulation market in India

For India, the future is likely a hybrid ecosystem: robust central laboratory analyzers complemented by decentralised, rapid-response coagulation devices. Sysmex is well positioned to operate across ...